Meningococcal Cases Rise in Vietnam; Experts Urge Travelers to Get Vaccinated

Cases of invasive meningococcal disease are on the rise in Vietnam, prompting health authorities to urge Korean travelers to take preventive measures before visiting the Southeast Asian nation.

According to the Korea Disease Control and Prevention Agency's recent report on global infectious disease trends, Vietnam has seen an uptick in meningococcal infections. Korean tourists represent a significant portion of international visitors to Vietnam, making advance preparation increasingly critical.

Meningococcal disease is an acute bacterial infection that can rapidly progress to meningitis or sepsis, medical experts said Monday. In Korea, it is classified as a Class 2 notifiable infectious disease requiring reporting within 24 hours of detection.

Early symptoms including fever, headache, loss of appetite, and nausea closely resemble the common cold, making the disease easy to mistake for a minor illness. However, the infection progresses extremely fast and can become life-threatening within hours if treatment is delayed.

Delayed treatment significantly increases mortality risk. Survivors may suffer severe complications including hearing loss, neurological damage, and limb necrosis. Experts emphasize the importance of awareness, as the condition can deteriorate rapidly even when initial symptoms appear mild.

Health specialists urge travelers to check infectious disease outbreaks in their destination countries before departure. Given rising meningococcal cases in Vietnam and other regions, reviewing preventive measures before travel is essential.

The bacteria spread through respiratory droplets from coughing or talking and through close contact. Risk increases in crowded living environments such as military barracks or dormitories, with infection possible during air travel or extended stays abroad.

Korean health authorities recommend vaccination for high-risk groups including those with underlying conditions, people in group living situations, visitors to Africa's meningitis belt, and pilgrims traveling to Mecca, Saudi Arabia.

The World Health Organization also recommends vaccination tailored to regional outbreak strains and high-risk populations as a primary response strategy. Prevention-focused approaches are crucial since treatment options become limited once symptoms appear.

A quadrivalent meningococcal vaccine available for infants as young as six weeks has been introduced in Korea, expanding preventive options. The vaccine protects against serogroups A, C, Y, and W and can be administered from infancy through adulthood.

Dosing schedules vary by age. Infants aged six weeks to under six months require four doses—three primary and one booster. Children aged six months to under 24 months need two doses. Those aged 2 to 55 years can achieve protection with a single dose.